Wealth Enhancement Advisory Services LLC Sells 18,940 Shares of Cigna Group $CI

Wealth Enhancement Advisory Services LLC lessened its stake in Cigna Group (NYSE:CI) by 17.3% in the third quarter, HoldingsChannel reports. The firm owned 90,629 shares of the health services provider’s stock after selling 18,940 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Cigna Group were worth $27,836,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CI. Valeo Financial Advisors LLC grew its position in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock worth $1,148,859,000 after buying an additional 3,471,249 shares during the period. Norges Bank bought a new position in Cigna Group during the 2nd quarter worth approximately $1,110,426,000. Arrowstreet Capital Limited Partnership boosted its stake in Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after acquiring an additional 492,045 shares during the last quarter. Balyasny Asset Management L.P. grew its holdings in Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after purchasing an additional 369,775 shares during the period. Finally, Man Group plc increased its stake in Cigna Group by 215.5% in the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after purchasing an additional 363,510 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the transaction, the chief executive officer directly owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on CI shares. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Sunday, December 28th. Truist Financial raised their price target on Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research report on Monday, January 5th. Mizuho set a $325.00 target price on Cigna Group in a research note on Friday, January 9th. Barclays raised their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “overweight” rating in a report on Monday, January 5th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a research report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $330.36.

Cigna Group Trading Up 1.3%

NYSE:CI opened at $274.84 on Thursday. The company has a market cap of $73.42 billion, a P/E ratio of 12.12, a price-to-earnings-growth ratio of 0.96 and a beta of 0.26. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The business has a 50 day moving average price of $274.07 and a two-hundred day moving average price of $286.09. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. During the same period last year, the company earned $7.51 earnings per share. The firm’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, analysts expect that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.